SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-17-006828
Filing Date
2017-01-10
Accepted
2017-01-10 16:06:55
Documents
1
Group Members
ANDREW G. BLUHMDSC ADVISORS, L.L.C.DSC ADVISORS, L.P.DSC MANAGERS, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d319845dsc13ga.htm SC 13G/A 85331
  Complete submission text file 0001193125-17-006828.txt   86986
Mailing Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050
Business Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050 972.408.1360
Neos Therapeutics, Inc. (Subject) CIK: 0001467652 (see all company filings)

IRS No.: 270395455 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88949 | Film No.: 17520655
SIC: 2834 Pharmaceutical Preparations

Mailing Address 900 N. MICHIGAN, SUITE 1600 CHICAGO IL 60611
Business Address 900 N. MICHIGAN, SUITE 1600 CHICAGO IL 60611 312-915-2886
Delaware Street Capital Master Fund, L.P. (Filed by) CIK: 0001648576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A